Hap Trading, LLC Moderna, Inc. Transaction History

Hap Trading, LLC

$840 Billion
Q2 2024

A detailed history of Hap Trading, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 19,900 shares of MRNA stock, worth $1.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

19,900

Previous 19,900 -0.0%

Holding current value

$1.31 Million

Previous $211 Million 31.2%

% of portfolio

0.02%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $652,281 - $979,971	-9,384 Reduced 38.91%	14,736 $1.47 Billion
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $2.33 Million - $3.05 Million	24,120 New	24,120 $2.49 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $450,703 - $837,718	3,564 Added 35.47%	13,611 $2.35 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $3.26 Million - $5.32 Million	-14,444 Reduced 58.98%	10,047 $2.55 Million
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $4.41 Million - $9.63 Million	-19,884 Reduced 44.81%	24,491 $9.43 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $3.82 Million - $6.91 Million	29,400 Added 196.33%	44,375 $10.4 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $979,672 - $1.67 Million	-8,973 Reduced 37.47%	14,975 $1.96 Million
Q1 2020 May 08, 2020	BUY	$17.78 - $31.58 $425,795 - $756,277	23,948 New	23,948 $717,000
Q4 2019 Feb 11, 2020	SELL	$13.93 - $21.28 $261,884 - $400,064	-18,800 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $230,488 - $339,716	18,800 New	18,800 $299,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account